Healthy Aging Research
Open Access

Polypharmacy and Its Impact on Cognitive Decline in Elderly Patients: A Longitudinal Analysis

5^th International Congress on Geriatrics and Gerontology

March 10-11, 2025 | Webinar

Fatima Al-Mansouri

Qatar University, Qatar

Scientific Tracks Abstracts: Clin Pediatr

Abstract :

Polypharmacy is common among elderly patients and is associated with increased risk of adverse cognitive outcomes. This longitudinal study followed 250 patients aged 70+ over 3 years to examine the relationship between the number of medications and cognitive decline. Results indicated that patients on â?¥5 medications had faster cognitive deterioration measured by the Mini-Mental State Examination, controlling for comorbidities. Deprescribing interventions were associated with stabilization of cognitive function. Careful medication review is crucial in geriatric care to minimize polypharmacy-related cognitive risks.

Biography :

Fatima Al-Mansouri specializes in pharmacological management in the elderly, focusing on polypharmacy and drug safety. She promotes evidence-based deprescribing protocols to optimize cognitive and functional outcomes.